Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02147769
Other study ID # 23894
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 2014
Est. completion date March 2018

Study information

Verified date April 2020
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Premature infants are at high risk for variations in blood pressure and oxygenation during the first few days of life. The immaturity of the premature brain may further predispose these infants to death or the development of neurologic problems. The relationship between unstable blood pressure and oxygen levels and brain injury has not been well elucidated.

This study investigates the utility of near-infrared spectroscopy (NIRS), a non-invasive oxygen-measuring device, to identify preterm infants at highest risk for brain injury or death.


Recruitment information / eligibility

Status Completed
Enrollment 111
Est. completion date March 2018
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender All
Age group N/A to 24 Hours
Eligibility Inclusion Criteria:

- inborn

- birth weight <= 1250 grams

- indwelling arterial catheter in place

- age <24 hours old

Exclusion Criteria:

- lethal chromosomal abnormality

- major congenital anomaly

- skin integrity insufficient to allow placement of NIRS sensors

- decision to not provide full intensive care

Study Design


Related Conditions & MeSH terms


Intervention

Device:
NIRS monitoring
All enrolled infants will undergo NIRS monitoring of cerebral oxygenation in addition to monitoring of continuous arterial blood pressure.

Locations

Country Name City State
United States University of Alabama Birmingham Alabama
United States Nationwide Children's Hospital Columbus Ohio
United States UT Southwestern Medical Center Dallas Texas
United States Yale-New Haven Children's Hospital New Haven Connecticut
United States Stanford University Palo Alto California
United States Santa Clara Valley Medical Center San Jose California
United States St. John's Children's Hospital Springfield Illinois

Sponsors (2)

Lead Sponsor Collaborator
Stanford University Medtronic - MITG

Country where clinical trial is conducted

United States, 

References & Publications (6)

Alderliesten T, Lemmers PM, Smarius JJ, van de Vosse RE, Baerts W, van Bel F. Cerebral oxygenation, extraction, and autoregulation in very preterm infants who develop peri-intraventricular hemorrhage. J Pediatr. 2013 Apr;162(4):698-704.e2. doi: 10.1016/j.jpeds.2012.09.038. Epub 2012 Nov 6. — View Citation

Caicedo A, De Smet D, Naulaers G, Ameye L, Vanderhaegen J, Lemmers P, Van Bel F, Van Huffel S. Cerebral tissue oxygenation and regional oxygen saturation can be used to study cerebral autoregulation in prematurely born infants. Pediatr Res. 2011 Jun;69(6):548-53. doi: 10.1203/PDR.0b013e3182176d85. — View Citation

Soul JS, Hammer PE, Tsuji M, Saul JP, Bassan H, Limperopoulos C, Disalvo DN, Moore M, Akins P, Ringer S, Volpe JJ, Trachtenberg F, du Plessis AJ. Fluctuating pressure-passivity is common in the cerebral circulation of sick premature infants. Pediatr Res. 2007 Apr;61(4):467-73. — View Citation

Verhagen EA, Hummel LA, Bos AF, Kooi EM. Near-infrared spectroscopy to detect absence of cerebrovascular autoregulation in preterm infants. Clin Neurophysiol. 2014 Jan;125(1):47-52. doi: 10.1016/j.clinph.2013.07.001. Epub 2013 Aug 22. — View Citation

Wong FY, Leung TS, Austin T, Wilkinson M, Meek JH, Wyatt JS, Walker AM. Impaired autoregulation in preterm infants identified by using spatially resolved spectroscopy. Pediatrics. 2008 Mar;121(3):e604-11. doi: 10.1542/peds.2007-1487. Epub 2008 Feb 4. — View Citation

Wong FY, Silas R, Hew S, Samarasinghe T, Walker AM. Cerebral oxygenation is highly sensitive to blood pressure variability in sick preterm infants. PLoS One. 2012;7(8):e43165. doi: 10.1371/journal.pone.0043165. Epub 2012 Aug 14. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Mortality Before Hospital Discharge Participants will be followed for the outcome of death prior to hospital discharge. Outcome measure will be assessed at the time of subject's initial discharge from the hospital (on average by 40 weeks postmenstrual age), but at a maximum of 1 year of life.
Primary Severe Central Nervous System (CNS) Morbidity Routine cranial ultrasound obtained within the first ten days of life will be utilized to detect grade 3 or 4 intraventricular hemorrhage, periventricular leukomalacia, significant ventriculomegaly, or white matter abnormalities. Outcome measure will be assessed on day 10 of life. Participants will be followed for neuroradiographic evidence of CNS morbidity in the first ten days of life
See also
  Status Clinical Trial Phase
Completed NCT05844709 - Effectiveness of Nursing Care Bundle for the Prevention of Intraventricular Hemorrhage in Preterm Infants
Active, not recruiting NCT02076373 - Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants Phase 3
Withdrawn NCT03390530 - Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage Phase 3
Terminated NCT01482559 - Management of Hypotension In the Preterm Infant Phase 3
Recruiting NCT06280872 - Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns N/A
Terminated NCT03543046 - Tortle Midliner and Intraventricular Hemorrhage N/A
Recruiting NCT05617833 - Safety of Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage Phase 1